Xeris Biopharma Holdings, Inc. (XERS)

Market price: $10.45

2 valuation methods

• EV / EBITDA: $1.31 to $6.20 (midpoint $2.46)
• EV / Revenue: $3.09 to $10.10 (midpoint $5.37)

Limited data — fewer than three valuation methods could be formed for this company; showing every method we can stand behind.